CITALOPRAM HYDROBROMIDE

Citalopram Hydrobromide Adverse Events Reported to the FDA Over Time

How are Citalopram Hydrobromide adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Citalopram Hydrobromide, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Citalopram Hydrobromide is flagged as the suspect drug causing the adverse event.

Most Common Citalopram Hydrobromide Adverse Events Reported to the FDA

What are the most common Citalopram Hydrobromide adverse events reported to the FDA?

Completed Suicide	1383 (2.19%)
Drug Interaction	1181 (1.87%)
Overdose	731 (1.16%)
Anxiety	672 (1.06%)
Depression	634 (1%)
Dizziness	633 (1%)
Serotonin Syndrome	599 (.95%)
Fall	576 (.91%)
Cardiac Arrest	575 (.91%)
Drug Toxicity	574 (.91%)
Tremor	569 (.9%)
	Show More
Agitation	563 (.89%)
Nausea	554 (.88%)
Suicide Attempt	547 (.87%)
Confusional State	542 (.86%)
Vomiting	529 (.84%)
Drug Exposure During Pregnancy	508 (.8%)
Suicidal Ideation	493 (.78%)
Hyponatraemia	476 (.75%)
Respiratory Arrest	465 (.74%)
Convulsion	449 (.71%)
Headache	431 (.68%)
Malaise	417 (.66%)
Somnolence	414 (.66%)
Drug Ineffective	405 (.64%)
Loss Of Consciousness	396 (.63%)
Diarrhoea	382 (.6%)
Multiple Drug Overdose	379 (.6%)
Fatigue	378 (.6%)
Condition Aggravated	371 (.59%)
Hypotension	353 (.56%)
Maternal Drugs Affecting Foetus	349 (.55%)
Insomnia	341 (.54%)
Intentional Overdose	328 (.52%)
Electrocardiogram Qt Prolonged	322 (.51%)
Hyperhidrosis	312 (.49%)
Aggression	294 (.47%)
Tachycardia	275 (.44%)
Multiple Drug Overdose Intentional	272 (.43%)
Feeling Abnormal	267 (.42%)
Restlessness	255 (.4%)
Asthenia	254 (.4%)
Death	231 (.37%)
Syncope	228 (.36%)
Cardio-respiratory Arrest	217 (.34%)
Dyspnoea	217 (.34%)
Coma	216 (.34%)
Pyrexia	216 (.34%)
Hypokalaemia	205 (.32%)
Depressed Level Of Consciousness	204 (.32%)
Paraesthesia	199 (.32%)
Grand Mal Convulsion	193 (.31%)
Abdominal Pain	188 (.3%)
Disturbance In Attention	188 (.3%)
Irritability	186 (.29%)
Pain	184 (.29%)
Weight Increased	184 (.29%)
Hypertension	181 (.29%)
Amnesia	180 (.29%)
Drug Abuse	178 (.28%)
Disorientation	177 (.28%)
Weight Decreased	177 (.28%)
Panic Attack	174 (.28%)
Gait Disturbance	172 (.27%)
Myoclonus	171 (.27%)
Hallucination	170 (.27%)
Abnormal Behaviour	169 (.27%)
Palpitations	169 (.27%)
Poisoning	169 (.27%)
Mydriasis	165 (.26%)
Memory Impairment	164 (.26%)
Haemoglobin Decreased	161 (.25%)
Rash	159 (.25%)
Bradycardia	158 (.25%)
Decreased Appetite	157 (.25%)
Psychotic Disorder	156 (.25%)
Drug Withdrawal Syndrome	153 (.24%)
Dyskinesia	153 (.24%)
Metabolic Acidosis	153 (.24%)
Anaemia	152 (.24%)
Heart Rate Increased	151 (.24%)
Pregnancy	149 (.24%)
Torsade De Pointes	149 (.24%)
Blood Pressure Increased	148 (.23%)
Urinary Tract Infection	143 (.23%)
Pulmonary Oedema	141 (.22%)
Blood Creatine Phosphokinase Increa...	140 (.22%)
Myalgia	140 (.22%)
Speech Disorder	140 (.22%)
White Blood Cell Count Increased	139 (.22%)
Hypoaesthesia	138 (.22%)
Inappropriate Antidiuretic Hormone ...	138 (.22%)
Pneumonia	137 (.22%)
Vision Blurred	137 (.22%)
Renal Failure	136 (.22%)
Alanine Aminotransferase Increased	135 (.21%)
International Normalised Ratio Incr...	133 (.21%)
Hypoglycaemia	131 (.21%)
Muscle Spasms	131 (.21%)
Dehydration	125 (.2%)
Delirium	125 (.2%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Citalopram Hydrobromide, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Citalopram Hydrobromide is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Citalopram Hydrobromide

What are the most common Citalopram Hydrobromide adverse events reported to the FDA?

Neurological	4338 (6.87%)
Suicidal And Self-injurious Behavio...	2648 (4.19%)
Cardiac Arrhythmias	2296 (3.64%)
Medication Errors	2221 (3.52%)
Therapeutic And Nontherapeutic Effe...	2183 (3.46%)
Anxiety Disorders	1850 (2.93%)
Chemical Injury And Poisoning	1772 (2.81%)
Gastrointestinal Signs	1725 (2.73%)
Respiratory	1651 (2.61%)
Movement Disorders	1464 (2.32%)
Cardiac And Vascular Investigations	1183 (1.87%)
	Show More
Injuries	1179 (1.87%)
Electrolyte And Fluid Balance Condi...	969 (1.53%)
Depressed Mood Disorders	926 (1.47%)
Hematology Investigations	910 (1.44%)
Seizures	892 (1.41%)
Muscle	886 (1.4%)
Deliria	844 (1.34%)
Neuromuscular	806 (1.28%)
Epidermal And Dermal Conditions	760 (1.2%)
Mental Impairment	728 (1.15%)
Sleep Disorders	692 (1.1%)
Psychiatric	650 (1.03%)
Infections - Pathogen Unspecified	643 (1.02%)
Disturbances In Thinking	641 (1.02%)
Personality Disorders	628 (.99%)
Hepatic And Hepatobiliary	617 (.98%)
Decreased And Nonspecific Blood Pre...	613 (.97%)
Gastrointestinal Motility And Defec...	577 (.91%)
Physical Examination Topics	577 (.91%)
Mood Disorders	504 (.8%)
Headaches	501 (.79%)
Water, Electrolyte And Mineral	483 (.76%)
Hepatobiliary	475 (.75%)
Lifestyle Issues	472 (.75%)
Skin Appendage Conditions	436 (.69%)
Toxicology And Therapeutic Drug Mon...	410 (.65%)
Central Nervous System Vascular	400 (.63%)
Lower Respiratory Tract Disorders	399 (.63%)
Urinary Tract Signs	388 (.61%)
Fatal Outcomes	385 (.61%)
Renal Disorders	382 (.6%)
Changes In Physical Activity	379 (.6%)
Vision	363 (.57%)
Ocular Neuromuscular	361 (.57%)
Gastrointestinal Hemorrhages	360 (.57%)
Appetite And General Nutritional	350 (.55%)
Metabolic, Nutritional And Blood Ga...	343 (.54%)
Musculoskeletal And Connective Tiss...	338 (.54%)
Cardiac Disorder Signs	321 (.51%)
Body Temperature Conditions	318 (.5%)
Gastrointestinal Ulceration And Per...	299 (.47%)
Enzyme	291 (.46%)
Cardiac And Vascular Disorders Cong...	268 (.42%)
Renal And Urinary Tract Investigati...	263 (.42%)
Anemias Nonhemolytic And Marrow Dep...	247 (.39%)
Neonatal And Perinatal Conditions	246 (.39%)
Coronary Artery	234 (.37%)
Acid-base	229 (.36%)
Joint	228 (.36%)
Psychiatric And Behavioural Symptom...	228 (.36%)
Glucose Metabolism Disorders	220 (.35%)
Schizophrenia And Other Psychotic	219 (.35%)
Allergic Conditions	216 (.34%)
Obstetric And Gynecological Therape...	212 (.34%)
Sexual Dysfunctions, Disturbances A...	212 (.34%)
Bone And Joint Injuries	203 (.32%)
Vascular Hypertensive	202 (.32%)
Manic And Bipolar Mood Disorders	193 (.31%)
White Blood Cell	186 (.29%)
Myocardial	183 (.29%)
Oral Soft Tissue Conditions	179 (.28%)
Sexual Function And Fertility	177 (.28%)
Bacterial Infectious	176 (.28%)
Vascular Hemorrhagic	172 (.27%)
Pregnancy, Labour, Delivery And Pos...	167 (.26%)
Product Quality Issues	165 (.26%)
Neurological, Special Senses And Ps...	163 (.26%)
Hypothalamus And Pituitary Gland	161 (.25%)
Vascular	161 (.25%)
Therapeutic Procedures And Supporti...	156 (.25%)
Heart Failures	153 (.24%)
Legal Issues	150 (.24%)
Neonatal Respiratory	148 (.23%)
Musculoskeletal And Connective Tiss...	138 (.22%)
Increased Intracranial Pressure And...	137 (.22%)
Salivary Gland Conditions	132 (.21%)
Abortions And Stillbirth	129 (.2%)
Platelet	129 (.2%)
Somatoform And Factitious	124 (.2%)
Breast	122 (.19%)
Gastrointestinal Conditions	116 (.18%)
Neurological Disorders Congenital	116 (.18%)
Protein And Chemistry Analyses	115 (.18%)
Procedural And Device Related Injur...	111 (.18%)
Skin Vascular Abnormalities	110 (.17%)
Gastrointestinal Inflammatory Condi...	108 (.17%)
Sleep Disturbances	104 (.16%)
Upper Respiratory Tract Disorders	104 (.16%)
Hearing	102 (.16%)
Gastrointestinal Tract Disorders Co...	100 (.16%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Citalopram Hydrobromide, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Citalopram Hydrobromide is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.